SCHEMBL11025920

SCHEMBL11025920

CSc1ncc2ccc3c(C(N)=O)nn(CC4CCN(C(=O)OC(C)(C)C)CC4)c3c2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 5/20 0.47
TTK P33981 5/20 0.47
PIM2 Q9P1W9 5/20 0.47
MERTK Q12866 1/20 0.40
GPR119 Q8TDV5 4/20 0.39
TGFBR1 P36897 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3R2 O00459 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
PIK3R5 Q8WYR1 1/20 0.39
PIK3R3 Q92569 1/20 0.39
CHEK2 O96017 2/20 0.37
SYK P43405 1/20 0.37
BACE1 P56817 1/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9940743 0.86 PIM1 (0.49) PIM1TTKPIM2GPR119CCNA2
SCHEMBL11938649 0.86 PIM1 (0.43) PIM1TTKPIM2JAK2JAK1
SCHEMBL10216356 0.83 PIM1 (0.48) PIM1TTKPIM2
SCHEMBL9940832 0.83 PIM1 (0.61) PIM1TTKPIM2MERTKCDK2
Hydrochloric Acid SCHEMBL11023711 0.83 PIM1 (0.47) PIM1TTKPIM2
Hydrochloric Acid SCHEMBL9940773 0.82 PIM1 (0.61) PIM1TTKPIM2MERTKCDK2
SCHEMBL11025619 0.81 PIM1 (0.43) PIM1TTKPIM2
SCHEMBL9940666 0.80 PIM1 (0.47) PIM1TTKPIM2CDK2
SCHEMBL12466396 0.79 PIM1 (0.72) PIM1TTKPIM2GPR119CCNA2
SCHEMBL9940823 0.78 PIM1 (0.54) PIM1TTKPIM2MERTKSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614065-B1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2017-04-19 EP disclosed
US-8541576-B2 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES SRL (IT) 2013-09-24 US disclosed
US-20120190678-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190678-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS PIM1, PIM2, PIM3 PIM1 1/4885TTK 291/4885PIM2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.